Healthcare - Press Releases

Date	Title	Company
20-May-2020	Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer	AstraZeneca
19-May-2020	Cell Sorting Market Revenue Growth and Business Opportunities for New Market Entrants	Markets and Markets Research Pvt. Ltd.
19-May-2020	Patient Safety and Risk Management Software Market to reach USD 2.2 Billion by the end of 2024	Markets and Markets Research Pvt. Ltd.
18-May-2020	Roche becomes founding partner of BaseLaunch Phase II	BaseLaunch
18-May-2020	New date announced for SMi’s Pharma Microbiology East Coast Conference	SMi Group
14-May-2020	Maintenance Therapy With PARP Inhibitor Olaparib Extends Survival By Over 1 Year in Patients With Relapsed Ovarian Cancer and BRCA Mutation	ASCO
14-May-2020	DefiniGEN launches tool for coronavirus-specific intestinal cell research	DefiniGEN
11-May-2020	Registration is now open for the 2nd annual Wearable Injectors and Connected Devices Conference 2020	SMi Group Ltd
11-May-2020	CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic	CluePoints
11-May-2020	Demand for immunity products to be sustained long-term say SIRIO	SIRIO
07-May-2020	Rothamsted Research answers White House call for coronavirus data help	Rothamsted Research
07-May-2020	Researchers launch race to develop sustainable COVID-19 vaccine delivery	University of Birmingham
07-May-2020	BioNTech Completes Acquisition of Neon Therapeutics	BioNTech
06-May-2020	SCOTTISH LIFE SCIENCE COMPANY DEVELOPS COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT	Arrayjet Limited
06-May-2020	Bone Therapeutics Provides First Quarter 2020 Business Update	Bone Therapeutics
06-May-2020	Antabio Receives QIDP Designation from the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens	Antabio SAS
06-May-2020	Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine Program	Bavarian Nordic
06-May-2020	Oxford Biomedica plc Preliminary results for the year ended 31 December 2019	Oxford Biomedica plc
06-May-2020	Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction	AstraZeneca
06-May-2020	Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards …	Synergy Vision (SV)